Resultados da busca - Olivier Peyruchaud

  • Mostrando 1 - 17 resultados de 17
Refinar Resultados
  1. 1
    Metastasis: new functional implications of platelets and megakaryocytes

    Metastasis: new functional implications of platelets and megakaryocytes por Raphaël Leblanc, Olivier Peyruchaud

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis

    Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis por Raphaël Leblanc, A Houssin, Olivier Peyruchaud

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases

    Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases por Fabienne Coury, Olivier Peyruchaud, Irma Machuca‐Gayet

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of Osteolytic Lesions

    Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of O... por Olivier Peyruchaud, Bent Winding, Isabelle Pécheur, Claire‐Marie Serre, Pierre Delmas, Philippe Clézardin

    Publicado em 2001
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

    The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases por Ahmed Boucharaba, Claire‐Marie Serre, Julien Guglielmi, Jean‐Claude Bordet, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2006
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity

    Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity por Olivier Peyruchaud, Claire‐Marie Serre, Róisı́n NicAmhlaoibh, Pierrick G.J. Fournier, Philippe Clézardin

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer

    The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer por Debashish Sahay, Raphaël Leblanc, Thomas G. P. Grünewald, Srikant Ambatipudi, Johnny Ribeiro, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms

    Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms por Boucharaba, Ahmed, Guillet, Benoit, Menaa, Farid, Hneino, Mohamed, van Wijnen, Andre J, Philippe, Clézardin, Olivier, Peyruchaud

    Publicado em 2009
    Obter o texto integral Obter o texto integral Obter o texto integral
    Texto
    Salvar na lista
    Na minha lista:
  9. 9
    Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis

    Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angioge... por Marion David, Johnny Ribeiro, Françoise Descôtes, Claire‐Marie Serre, M. Barbier, Maximilien Murone, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases

    Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases por Yingshe Zhao, Richard Bachelier, Isabelle Treilleux, Philippe Pujuguet, Olivier Peyruchaud, Roland Baron, Philippe Clément-Lacroix, Philippe Clézardin

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

    Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer por Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès, Jean Sébastien Saulnier‐Blache, Jean‐Claude Bordet, Julien Guglielmi, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Murine models of breast cancer bone metastasis

    Murine models of breast cancer bone metastasis por Laura E. Wright, Penelope D. Ottewell, Nadia Rucci, Olivier Peyruchaud, Gabriel M. Pagnotti, Antonella Chiechi, Jeroen T. Buijs, Julie A. Sterling

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

    Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer por Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès, Jean Sébastien Saulnier‐Blache, Jean‐Claude Bordet, Julien Guglielmi, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer

    BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer por Marie Ouarné, Claire Bouvard, Gabriela Boneva, Christine Mallet, Johnny Ribeiro, Agnès Desroches‐Castan, Emmanuelle Soleilhac, Emmanuelle Tillet, Olivier Peyruchaud, Sabine Bailly

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone

    Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone por Raphaël Leblanc, Sue-Chin Lee, Marion David, Jean‐Claude Bordet, Derek D. Norman, Renukadevi Patil, Duane D. Miller, Debashish Sahay, Johnny Ribeiro, Philippe Clézardin, Gábor Tigyi, Olivier Peyruchaud

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts

    Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts por Marion David, Estelle Wannecq, Françoise Descôtes, Silvia Jansen, Blandine Deux, Johnny Ribeiro, Claire‐Marie Serre, Sandra Grès, Nathalie Bendriss‐Vermare, Mathieu Bollen, S Saez, Junken Aoki, Jean Sébastien Saulnier‐Blache, Philippe Clézardin, Olivier Peyruchaud

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors

    Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors por Marcel A. Deken, Karolina Niewola‐Staszkowska, Olivier Peyruchaud, N. Mikulčić, Maja Antolić, Pritom Shah, Anne Cheasty, Alessia Tagliavini, Andrea Nizzardo, M. Pergher, Luigi Ziviani, Stefano Milleri, C. Pickering, M. Lahn, Lars van der Veen, Giusy Di Conza, Zoë Johnson

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: